90 related articles for article (PubMed ID: 9365456)
1. Losartan-associated atypical cutaneous lymphoid hyperplasia.
Viraben R; Lamant L; Brousset P
Lancet; 1997 Nov; 350(9088):1366. PubMed ID: 9365456
[No Abstract] [Full Text] [Related]
2. [Misleading or rare cutaneous drug reactions].
Souteyrand P; d'Incan M; Parent S
Rev Prat; 2000 Jun; 50(12):1329-33. PubMed ID: 10972075
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).
Bocquet H; Bagot M; Roujeau JC
Semin Cutan Med Surg; 1996 Dec; 15(4):250-7. PubMed ID: 9069593
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous lymphoid hyperplasia following vaccine for pollen hyposensitization.
Porriño-Bustamante ML; Aneiros-Fernández J; Retámero JA; Sánchez-López J; Fernández-Pugnaire MA
Indian J Dermatol Venereol Leprol; 2016; 82(2):193-5. PubMed ID: 26765127
[No Abstract] [Full Text] [Related]
5. Cutaneous lymphoid hyperplasia related to squaric acid dibutyl ester.
Millican EA; Conley JA; Sheinbein D
J Am Acad Dermatol; 2011 Jul; 65(1):230-2. PubMed ID: 21679832
[No Abstract] [Full Text] [Related]
6. Cutaneous pseudolymphoma after patch test to gold sodium thiosulfate in two patients.
García-Arpa M; Gómez-Torrijos E; Relea-Calatayud F; Santiago-Sánchez Mateos JL; Galindo-Bonilla PA; Carmona-Rodríguez M
Contact Dermatitis; 2020 May; 82(5):322-324. PubMed ID: 31925792
[No Abstract] [Full Text] [Related]
7. Cutaneous pseudolymphoma arising after tattoo placement.
Gutermuth J; Hein R; Fend F; Ring J; Jakob T
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):566-7. PubMed ID: 17374006
[No Abstract] [Full Text] [Related]
8. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
[No Abstract] [Full Text] [Related]
9. Pseudolymphoma at site of clonidine patch.
Shelley WB; Shelley ED
Lancet; 1997 Oct; 350(9086):1223-4. PubMed ID: 9652568
[No Abstract] [Full Text] [Related]
10. Cutaneous B-cell Pseudolymphoma in a Psoriatic Patient Treated with Cyclosporine.
Takahashi T; Hata M; Iwata H; Seishima M
Acta Derm Venereol; 2016 Aug; 96(6):824-5. PubMed ID: 26928776
[No Abstract] [Full Text] [Related]
11. Cutaneous pseudolymphoma following administration of lornoxicam.
Stavrianeas NG; Katoulis AC; Bozi E; Toumbis-Ioannou E; Kanelleas AI; Makris M; Kalogeromitros D; Panayiotides I
Acta Derm Venereol; 2007; 87(5):453-5. PubMed ID: 17721665
[No Abstract] [Full Text] [Related]
12. Cutaneous pseudolymphoma occurring during methotrexate therapy for rheumatoid arthritis.
Flipo RM; Delaporte E; Lecomte-Houcke M
J Rheumatol; 1997 Apr; 24(4):809-10. PubMed ID: 9101529
[No Abstract] [Full Text] [Related]
13. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities.
Callot V; Roujeau JC; Bagot M; Wechsler J; Chosidow O; Souteyrand P; Morel P; Dubertret L; Avril MF; Revuz J
Arch Dermatol; 1996 Nov; 132(11):1315-21. PubMed ID: 8915309
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous pseudolymphoma associated with bromocriptine therapy.
Wiesli P; Joos L; Galeazzi RL; Dummer R
Clin Endocrinol (Oxf); 2000 Nov; 53(5):656-7. PubMed ID: 11106930
[No Abstract] [Full Text] [Related]
15. [Cutaneous pseudolymphoma caused by carbamazepine].
d'Incan M; Mouillet ML; Roger H; Ferrier MC; Buono JP; Déchelotte P; Bignon YJ; Souteyrand P
Ann Dermatol Venereol; 1998 Jan; 125(1):52-5. PubMed ID: 9747211
[TBL] [Abstract][Full Text] [Related]
16. Vaccination-induced cutaneous pseudolymphoma.
Maubec E; Pinquier L; Viguier M; Caux F; Amsler E; Aractingi S; Chafi H; Janin A; Cayuela JM; Dubertret L; Authier FJ; Bachelez H
J Am Acad Dermatol; 2005 Apr; 52(4):623-9. PubMed ID: 15793512
[TBL] [Abstract][Full Text] [Related]
17. Injection-Site Cutaneous Pseudolymphoma Induced by a GM-CSF-Producing Tumor Cell Vaccine.
Staser K; Abner S; Anadkat M; Musiek A; Schaffer A
JAMA Dermatol; 2017 Apr; 153(4):332-334. PubMed ID: 28114617
[No Abstract] [Full Text] [Related]
18. Zoledronic acid-induced cutaneous B-cell pseudolymphoma.
Kitagawa KH; Grassi M
J Am Acad Dermatol; 2011 Dec; 65(6):1238-40. PubMed ID: 22082850
[No Abstract] [Full Text] [Related]
19. Cutaneous T cell pseudolymphoma at the site of a semipermanent lip-liner tattoo.
Shin JB; Seo SH; Kim BK; Kim IH; Son SW
Dermatology; 2009; 218(1):75-8. PubMed ID: 19005245
[No Abstract] [Full Text] [Related]
20. A case of cutaneous pseudolymphoma associated with silicone injection.
Lee MW; Choi JH; Sung KJ; Moon KC; Koh JK
Acta Derm Venereol; 2004; 84(4):312-3. PubMed ID: 15339080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
